Correlates of adherence to respiratory drugs in COPD patients.

AIMS To identify the correlates of accidental omissions and intentional interruptions of respiratory therapy in COPD. METHODS COPD patients (GOLD stages II-IV) were recruited by general practitioners or respiratory physicians. Patients reported in self-report questionnaires their adherence to respiratory drugs (over the past three months) and their perception of therapy. RESULTS 179 patients were included (mean age 63 years, 24% females). 45% forgot their respiratory therapy, while 30% interrupted it in the absence of any perceived benefit. The risks of accidental omissions were significantly higher when patients complained about having too many medications to take on a daily basis (OR=2.35; 95%CI=1.13-4.89), and among current smokers (OR=2.14; 95%CI=1.07-4.29). Females were more likely to interrupt therapy intentionally (OR=2.40; 95%CI=1.04-5.53). Surprisingly, there was no significant relationship with the number of drugs actually taken by patients. CONCLUSIONS Adherence to respiratory drugs is inadequate in COPD patients. In order to improve adherence, patients' perception of the burden of therapy should not be overlooked.

[1]  J. Bourbeau,et al.  Patient adherence in COPD , 2008, Thorax.

[2]  John Urquhart,et al.  Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories , 2008, BMJ : British Medical Journal.

[3]  L. Ring,et al.  Refill adherence by the elderly for asthma/chronic obstructive pulmonary disease drugs dispensed over a 10‐year period , 2007, Journal of clinical pharmacy and therapeutics.

[4]  P. Camp,et al.  Gender and the diagnosis, management, and surveillance of chronic obstructive pulmonary disease. , 2007, Proceedings of the American Thoracic Society.

[5]  J. George,et al.  Adherence to disease management programs in patients with COPD , 2007, International journal of chronic obstructive pulmonary disease.

[6]  Albert Alonso,et al.  Effects of an integrated care intervention on risk factors of COPD readmission. , 2007, Respiratory medicine.

[7]  M. Decramer,et al.  Integrated care prevents hospitalisations for exacerbations in COPD patients , 2006, European Respiratory Journal.

[8]  S. Erickson,et al.  Self-Reported Adherence in Patients with Asthma , 2006, The Annals of pharmacotherapy.

[9]  K. R. Chapman,et al.  Epidemiology and costs of chronic obstructive pulmonary disease , 2006, European Respiratory Journal.

[10]  C. Lenfant,et al.  Global Initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease , 2006 .

[11]  J. George,et al.  Factors associated with medication nonadherence in patients with COPD: Chest 2005;128:3198–204 , 2006 .

[12]  H. S. Lau,et al.  Non-compliance in elderly people: evaluation of risk factors by longitudinal data analysis , 1996, Pharmacy World and Science.

[13]  L. Osman,et al.  Factors affecting adherence to asthma treatment: patient and physician perspectives. , 2003, Primary care respiratory journal : journal of the General Practice Airways Group.

[14]  J. Izquierdo,et al.  The burden of COPD in Spain: results from the Confronting COPD survey. , 2003, Respiratory medicine.

[15]  T. Similowski,et al.  The burden of COPD in France: results from the Confronting COPD survey. , 2003, Respiratory medicine.

[16]  P. Vermeire,et al.  The burden of chronic obstructive pulmonary disease. , 2002, Respiratory medicine.

[17]  W. Bailey,et al.  Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution , 2023, Medical science monitor : international medical journal of experimental and clinical research.

[18]  M. Earnest.  Explaining adherence to supplemental oxygen therapy: the patient's perspective. , 2002, Journal of general internal medicine.

[19]  J. Cramer,et al.  A systematic review of the associations between dose regimens and medication compliance. , 2001, Clinical therapeutics.

[20]  M. Greenstone,et al.  How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer , 2000, Thorax.

[21]  M. Dimatteo,et al.  Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. , 2000, Archives of internal medicine.

[22]  S. Hurd,et al.  The impact of COPD on lung health worldwide: epidemiology and incidence. , 2000, Chest.

[23]  C. van Weel,et al.  Compliance During Long-Term Treatment with Fluticasone Propionate in Subjects with Early Signs of Asthma or Chronic Obstructive Pulmonary Disease (COPD): Results of the Detection, Intervention, and Monitoring Program of COPD and Asthma (DIMCA) Study , 2000, The Journal of asthma : official journal of the Association for the Care of Asthma.

[24]  R. Zuwallack,et al.  Adherence with twice-daily dosing of inhaled steroids. Socioeconomic and health-belief differences. , 1998, American journal of respiratory and critical care medicine.

[25]  G. Cochrane,et al.  Home nebulized therapy for patients with COPD: patient compliance with treatment and its relation to quality of life. , 1997, Chest.

[26]  N. Anthonisen,et al.  Predictors of patient adherence to long-term home nebulizer therapy for COPD. The IPPB Study Group. Intermittent Positive Pressure Breathing. , 1995, Chest.

[27]  M. Cowles,et al.  Long-term metered-dose inhaler adherence in a clinical trial. The Lung Health Study Research Group. , 1995, American journal of respiratory and critical care medicine.

[28]  W. Bailey,et al.  Medication adherence patterns in chronic obstructive pulmonary disease. , 1991, Chest.

[29]  M. J. Dulfano,et al.  Intermittent positive pressure breathing; its use in the inspiratory phase of respiration. , 1954, The New England journal of medicine.